http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5732215-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate | 1980-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_843c54d61b0b19db5d4c2fd08571e979 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc12432fd0801ac2d67de37821e60671 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb01d3c9f7e67f11d697bbcecfdcbaa3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b6eb8144f53b44b93521a8fcc5d4bd4 |
| publicationDate | 1982-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S5732215-A |
| titleOfInvention | Powdery pharmacological composition and powder for application to internasal mucous membrane |
| abstract | PURPOSE: The titled composition and powder, consisting of a lower alkyl ether of cellulose having a specific viscosity of an aqueous solution thereof under specifed conditions and a pharmacologically effective amount of a drug, having a specific particle diameter, and capable of exhibiting the prolonged release of the drug and a high drug utilization efficiency. n CONSTITUTION: A composition consisting of a lower alkyl ether of cellulose, particularly hydroxypropyl cellulose, having a viscosity of about 5cps or above, preferably about 5W5,000cps, in a 2wt% aqueous solution thereof at about 37°C and a pharamacologically effective amount of a drug, preferably a remedy or preventing agent for nasal diseases. 90wt% or more particles have an effective particle diameter of about 20W250μ, particularly about 20W150μ. The composition adheres to the intranasal mucous membrane to absorb water and become a liquid state having a suitable tackiness and fluidity by the administration to the intranasal cavity. The administered composition moves slowly on the nasal mucous membrance as a flowing surface and imparts the prolonged release of the drug and a high drug utilization efficiency. n COPYRIGHT: (C)1982,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6237016-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6881423-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7731990-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8206748-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4765020-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-722319-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6572893-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5972388-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4579858-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9731626-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59163313-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007504129-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9325198-A1 |
| priorityDate | 1980-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.